{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T02:06:47Z","timestamp":1782007607181,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"FOXG1 Research Foundation"},{"name":"Citizen Health"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurodevelop Disord"],"DOI":"10.1186\/s11689-025-09653-1","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:34:55Z","timestamp":1761298495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Longitudinal characterization of clinical, developmental, and behavioral phenotypes in 101 children and adults with FOXG1 syndrome"],"prefix":"10.1186","volume":"17","author":[{"given":"Elise","family":"Brimble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam","family":"Ventola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Blomenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Frahlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kopika","family":"Kuhathaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Bahi-Buisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather E.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric D.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gai","family":"Ayalon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"4","key":"9653_CR1","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.devcel.2009.03.007","volume":"16","author":"C Danesin","year":"2009","unstructured":"Danesin C, Peres JN, Johansson M, Snowden V, Cording A, Papalopulu N, et al. Integration of telencephalic Wnt and Hedgehog signaling center activities by Foxg1. Dev Cell. 2009;16(4):576\u201387.","journal-title":"Dev Cell"},{"issue":"6","key":"9653_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1136\/jmg.2010.087528","volume":"48","author":"F Kort\u00fcm","year":"2011","unstructured":"Kort\u00fcm F, Das S, Flindt M, Morris-Rosendahl DJ, Stefanova I, Goldstein A, et al. The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. J Med Genet. 2011;48(6):396\u2013406.","journal-title":"J Med Genet"},{"issue":"1","key":"9653_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/gim.2017.75","volume":"20","author":"D Mitter","year":"2018","unstructured":"Mitter D, Pringsheim M, Kaulisch M, Pl\u00fcmacher KS, Schr\u00f6der S, Warthemann R, et al. FOXG1 syndrome: genotype\u2013phenotype association in 83 patients with FOXG1 variants. Genet Med. 2018;20(1):98\u2013108.","journal-title":"Genet Med"},{"issue":"6","key":"9653_CR4","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000281","volume":"4","author":"N Vegas","year":"2018","unstructured":"Vegas N, Cavallin M, Maillard C, Boddaert N, Toulouse J, Schaefer E, et al. Delineating FOXG1 syndrome: from congenital microcephaly to hyperkinetic encephalopathy. Neurol Genet. 2018;4(6):e281.","journal-title":"Neurol Genet"},{"issue":"1","key":"9653_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13023-023-02745-y","volume":"18","author":"E Brimble","year":"2023","unstructured":"Brimble E, Reyes KG, Kuhathaas K, Devinsky O, Ruzhnikov MRZ, Ortiz-Gonzalez XR, et al. Expanding genotype\u2013phenotype correlations in FOXG1 syndrome: results from a patient registry. Orphanet J Rare Dis. 2023;18(1):149.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"9653_CR6","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/acn3.735","volume":"6","author":"M Pringsheim","year":"2019","unstructured":"Pringsheim M, Mitter D, Schr\u00f6der S, Warthemann R, Pl\u00fcmacher K, Kluger G, et al. Structural brain anomalies in patients with FOXG1 syndrome and in Foxg1+\/\u2013 mice. Ann Clin Transl Neurol. 2019;6(4):655\u201368.","journal-title":"Ann Clin Transl Neurol"},{"key":"9653_CR7","doi-asserted-by":"crossref","unstructured":"Mazel B, Delanne J, Garde A, Racine C, Bruel AL, Duffourd Y, et al. FOXG1 variants can be associated with milder phenotypes than congenital Rett syndrome with unassisted walking and language development. Am J Med Genet B Neuropsychiatr Genet. 2024;n\/a(n\/a):e32970.","DOI":"10.1002\/ajmg.b.32970"},{"key":"9653_CR8","doi-asserted-by":"crossref","unstructured":"Jeon S, Park J, Likhite S, Moon JH, Shin D, Li L et al. The postnatal injection of AAV9-FOXG1 rescues corpus callosum agenesis and other brain deficits in the mouse model of FOXG1 syndrome. Mol Ther Methods Clin Dev [Internet]. 2024 Sep 12 [cited 2024 Aug 7];32(3). Available from: https:\/\/www.cell.com\/molecular-therapy-family\/methods\/abstract\/S2329-0501(24)00091-3","DOI":"10.1016\/j.omtm.2024.101275"},{"issue":"5","key":"9653_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"key":"9653_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1109547","volume":"14","author":"EM Spelbrink","year":"2023","unstructured":"Spelbrink EM, Brown TL, Brimble E, Blanco KA, Nye KL, Porter BE. Characterizing a rare neurogenetic disease, SLC13A5 citrate transporter disorder, utilizing clinical data in a cloud-based medical record collection system. Front Genet. 2023;14:1109547.","journal-title":"Front Genet"},{"key":"9653_CR11","doi-asserted-by":"publisher","unstructured":"Brimble E, Kim J, Martin RL, McKnight D, Lacoste AMB. Computation of longitudinal phenotypes in 466 individuals with a developmental and epileptic encephalopathy enables clinical trial readiness [Internet]. medRxiv; 2023 [cited 2024 Aug 7]. p. 2023.03.02.23286645. Available from: https:\/\/www.medrxiv.org\/content\/https:\/\/doi.org\/10.1101\/2023.03.02.23286645v2","DOI":"10.1101\/2023.03.02.23286645v2"},{"issue":"4","key":"9653_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1469-8749.1997.tb07414.x","volume":"39","author":"R Palisano","year":"1997","unstructured":"Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214\u201323.","journal-title":"Dev Med Child Neurol"},{"issue":"7","key":"9653_CR13","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1017\/S0012162206001162","volume":"48","author":"AC Eliasson","year":"2006","unstructured":"Eliasson AC, Krumlinde-Sundholm L, R\u00f6sblad B, Beckung E, Arner M, \u00d6hrvall AM, et al. The manual ability classification system (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol. 2006;48(7):549\u201354.","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"9653_CR14","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1469-8749.2011.03996.x","volume":"53","author":"MJC Hidecker","year":"2011","unstructured":"Hidecker MJC, Paneth N, Rosenbaum PL, Kent RD, Lillie J, Eulenberg JB, et al. Developing and validating the communication function classification system for individuals with cerebral palsy. Dev Med Child Neurol. 2011;53(8):704\u201310.","journal-title":"Dev Med Child Neurol"},{"issue":"8","key":"9653_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/sleep\/23.8.1d","volume":"23","author":"JA Owens","year":"2000","unstructured":"Owens JA, Spirito A, McGuinn M. The children\u2019s sleep habits questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep. 2000;23(8):1043\u201351.","journal-title":"Sleep"},{"issue":"5","key":"9653_CR16","first-page":"492","volume":"89","author":"MG Aman","year":"1985","unstructured":"Aman MG, Singh NN, Stewart AW, Field CJ. Psychometric characteristics of the aberrant behavior checklist. Am J Ment Defic. 1985;89(5):492\u2013502.","journal-title":"Am J Ment Defic"},{"issue":"10","key":"9653_CR17","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3390\/brainsci11101317","volume":"11","author":"JK Chawla","year":"2021","unstructured":"Chawla JK, Bernard A, Heussler H, Burgess S, Sleep. Function, behaviour and cognition in a cohort of children with down syndrome. Brain Sci. 2021;11(10):1317.","journal-title":"Brain Sci"},{"issue":"19","key":"9653_CR18","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1212\/WNL.0000000000002585","volume":"86","author":"A Papandreou","year":"2016","unstructured":"Papandreou A, Schneider RB, Augustine EF, Ng J, Mankad K, Meyer E, et al. Delineation of the movement disorders associated with FOXG1 mutations. Neurology. 2016;86(19):1794\u2013800.","journal-title":"Neurology"},{"issue":"3","key":"9653_CR19","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF01048240","volume":"22","author":"EC Marshburn","year":"1992","unstructured":"Marshburn EC, Aman MG. Factor validity and norms for the aberrant behavior checklist in a community sample of children with mental retardation. J Autism Dev Disord. 1992;22(3):357\u201373.","journal-title":"J Autism Dev Disord"},{"issue":"6","key":"9653_CR20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1002\/ajmg.a.61140","volume":"179","author":"A Sadhwani","year":"2019","unstructured":"Sadhwani A, Willen JM, LaVallee N, Stepanians M, Miller H, Peters SU, et al. Maladaptive behaviors in individuals with Angelman syndrome. Am J Med Genet A. 2019;179(6):983\u201392.","journal-title":"Am J Med Genet A"},{"key":"9653_CR21","doi-asserted-by":"publisher","unstructured":"Percy AK, Neul JL, Benke TA, Marsh ED, Glaze DG. A review of the Rett Syndrome Behaviour Questionnaire and its utilization in the assessment of symptoms associated with Rett syndrome. Front Pediatr [Internet]. 2023 Jul 28 [cited 2024 Aug 7];11. Available from: https:\/\/www.frontiersin.org\/journals\/pediatrics\/articles\/https:\/\/doi.org\/10.3389\/fped.2023.1229553\/full","DOI":"10.3389\/fped.2023.1229553\/full"},{"issue":"1","key":"9653_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s13023-021-01805-5","volume":"16","author":"PK Tandon","year":"2021","unstructured":"Tandon PK, Kakkis ED. The multi-domain responder index: a novel analysis tool to capture a broader assessment of clinical benefit in heterogeneous complex rare diseases. Orphanet J Rare Dis. 2021;16(1):183.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"9653_CR23","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ymgme.2022.09.001","volume":"137","author":"JB Eisengart","year":"2022","unstructured":"Eisengart JB, Daniel MH, Adams HR, Williams P, Kuca B, Shapiro E. Increasing precision in the measurement of change in pediatric neurodegenerative disease. Mol Genet Metab. 2022;137(1):201\u20139.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"9653_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s11689-023-09502-z","volume":"15","author":"JL Neul","year":"2023","unstructured":"Neul JL, Benke TA, Marsh ED, Suter B, Silveira L, Fu C, et al. Top caregiver concerns in Rett syndrome and related disorders: data from the US natural history study. J Neurodev Disord. 2023;15(1):33.","journal-title":"J Neurodev Disord"},{"key":"9653_CR25","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ejpn.2023.07.007","volume":"46","author":"BB Reeve","year":"2023","unstructured":"Reeve BB, Lucas N, Chen D, McFatrich M, Jones HN, Gordon KL, et al. Validation of the observer-reported communication ability (ORCA) measure for individuals with Rett syndrome. Eur J Paediatr Neurol. 2023;46:74\u201381.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"9653_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1352\/1944-7558-128.3.204","volume":"128","author":"CK Zigler","year":"2023","unstructured":"Zigler CK, Lin L, McFatrich M, Lucas N, Gordon KL, Jones HN, et al. Validation of the observer-reported communication ability (ORCA) measure for individuals with Angelman syndrome. Am J Intellect Dev Disabil. 2023;128(3):204\u201318.","journal-title":"Am J Intellect Dev Disabil"},{"key":"9653_CR27","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research, Office of Orphan Products Development. Guidance for Industry: Rare Diseases: Natural History Studies for Drug Development. 2019 Mar."},{"key":"9653_CR28","unstructured":"U.S. Department of Health and Human Services. Food and drug administration, center for drug evaluation and research, center for biologics evaluation and research, oncology center of excellence. Guidance for Industry: Considerations for the Design and Conduct of Externally Controlled Trials for Drug and Biological Products; 2023 Feb."}],"container-title":["Journal of Neurodevelopmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-025-09653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11689-025-09653-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11689-025-09653-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:34:59Z","timestamp":1761298499000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneurodevdisorders.biomedcentral.com\/articles\/10.1186\/s11689-025-09653-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9653"],"URL":"https:\/\/doi.org\/10.1186\/s11689-025-09653-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5582753\/v1","asserted-by":"object"}]},"ISSN":["1866-1955"],"issn-type":[{"value":"1866-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Caregivers and\/or legal guardians of study participants provided broad consent to share de-identified data for research. This study received determinations of exemption through a central institutional review board via exemption categories 2, 7, and 8 of the revised Common Rule.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Elise Brimble, Elizabeth Blomenberg, and Kelsey Frahlich are current employees of Citizen Health with vested and unvested stock options. Kopika Kuhathaas and Gai Ayalon are current employees of FOXG1 Research Foundation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}